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OBJECTIVE— To determine random capillary blood glucose (RCBG) cut points that dis-
criminate diabetic and pre-diabetic subjects from normal individuals.
RESEARCH DESIGN AND METHODS— RCBG was performed in 1,333 individuals
randomly chosen from 63,305 individuals who had participated in an opportunistic screening
program. An oral glucose tolerance test was also performed by venous plasma glucose on an
autoanalyzer. RCBG cut points that discriminate diabetes, impaired glucose tolerance (IGT), and
impaired fasting glucose (IFG) were determined using receiver operating characteristic curves.
RESULTS— Using 2-h plasma glucose 200 mg/dl (11.1 mmol/l) criterion, the RCBG cut
point of 140 mg/dl (7.7 mmol/l) gave the highest sensitivity and specificity. For 2-h plasma
glucose200 mg/dl (11.1 mmol/l) and fasting plasma glucose (FPG)126 mg/dl (7.0 mmol/l)
criteria, either 2-h plasma glucose200 mg/dl (11.1 mmol/l) or FPG126 mg/dl (7.0 mmol/l)
criterion, and the FPG126 mg/dl (7.0 mmol/l) criterion, RCBG cut point was 143 mg/dl (7.9
mmol/l). RCBG cut points for IGT, IFG according to World Health Organization criterion, and
IFG according to American Diabetes Association criterion were 119 mg/dl (6.6 mmol/l), 118
mg/dl (6.6 mmol/l), and 113 mg/dl (6.3 mmol/l), respectively.
CONCLUSIONS— Asian Indians with RCBG 110 mg/dl at screening can be recom-
mended to undergo definitive testing.
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A pproximately 50 –70% of peoplewith diabetes remain undiagnosedin both developed (1) and develop-
ing countries (2), and these individuals
often present with diabetes complications
(3). It is established that good control of
diabetes can prevent complications. Un-
diagnosed diabetes and pre-diabetes
therefore need to be detected and treated
early through community-based screen-
ing (4).
Definitions of diabetes are usually
based on fasting or postprandial glucose.
However, random capillary blood glucose
(RCBG) is the most convenient way to
reach large numbers of people. A few
studies in Western countries (5,6) have
tried to correlate RCBG with 2-h plasma
glucose or fasting plasma glucose (FPG)
(the basis for the World Health Organiza-
tion [WHO] and American Diabetes As-
sociation [ADA] definitions) but none
from India, which has the largest number
of people with diabetes globally (7). There
are also no data on RCBG cut points for
pre-diabetes states such as impaired fast-
ing glucose (IFG) and impaired glucose
tolerance (IGT). This is particularly rele-
vant because IFG now has two defini-
t ions: 100 mg/dl (5.6 mmol/ l )
according to ADA (8) and 110 mg/dl
(6.1 mmol/l) according to WHO (9).
The aim of this study, carried out in
a community setting in southern India,
was to derive RCBG cut points that dis-
criminate diabetic from nondiabetic
and pre-diabetic from non–pre-diabetic
individuals.
RESEARCH DESIGN AND
METHODS— Between September
2004 and September 2007, 774 opportu-
nistic diabetes screening camps evaluat-
ing 103,878 people were conducted in
various parts of Chennai (formerly Ma-
dras), India, with a population of 5 mil-
lion in southern India, as part of the
Prevention Awareness Counselling and
Evaluation (PACE) Diabetes Project. Of
these, 76,645 (73.8%) individuals under-
went an RCBG test using One Touch Ultra
(Lifescan, Johnson & Johnson, Milpitas,
CA). The detailed methodology of this
project is described elsewhere (10).
Individuals with self-reported diabe-
tes (n  13,340) were excluded. Of the
remaining 63,305 subjects, 1,500 indi-
viduals were randomly selected and in-
vited to attend Dr. Mohan’s Diabetes
Specialities Centre, a tertiary referral cen-
ter for diabetes care, to undergo an oral
glucose tolerance test within the next 2 to
3 days. A total of 1,333 individuals re-
sponded to the invitation (88.9% re-
sponse rate). A sample was drawn for FPG
estimation, 75 g of oral glucose was given,
and a second sample was drawn at 120
min (2-h plasma glucose).
Statistical analysis
Statistical analysis was performed using
SPSS for PC Windows, version 10.0
(SPSS, Chicago, IL). Receiver operating
characteristic curves were plotted using
sensitivity and 1-specificity for different
cutoff values of RCBG. Using the receiver
operating characteristic technique, com-
parison of sensitivity with specificity was
made over the entire range of RCBG cut
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points, and areas under the curve were
plotted. By interpolation from the area
under the curve, the point closest to the
upper-left corner, which maximized sen-
sitivity and specificity, was selected; this
identified the highest number of subjects
with or without a diabetes condition (11).
In this manner, RCBG cut points were de-
termined for diabetes, IGT, and IFG using
ADA (8) and WHO (9) criteria (supple-
mental Figure 1A, available in an online
appendix at http://care.diabetesjournals.
org/cgi/content/full/dc08-0403/DC1).
RESULTS— For the study group,
mean  SD age was 45.5  10.7 years,
BMI was 24.8  4.0 kg/m2, and 45.2%
were men. Additionally, 27.2% (n 363)
had RCBG 100 mg/dl (5.6 mmol/l),
65.9% (n  878) had RCBG in the range
of 100–200 mg/dl (5.6–11.1 mmol/l),
and 6.9% (n  92) had RCBG 200
mg/dl (11.1 mmol/l).
Using the 2-h plasma glucose 200
mg/dl (11.1 mmol/l) criterion, the RCBG
cut point of 140 mg/dl (7.7 mmol/l) gave
the highest sensitivity and specificity (Ta-
ble 1). Using the 2-h plasma glucose
200 mg/dl (11.1 mmol/l) and FPG
126 mg/dl (7.0 mmol/l) criteria, either
2-h plasma glucose 200 mg/dl (11.1
mmol/l) or FPG126 mg/dl (7.0 mmol/l)
criterion, or for FPG 126 mg/dl (7.0
mmol/l) criterion, the RCBG cut point
was 143 mg/dl (7.9 mmol/l).
For IGT, the RCBG cut point was 119
mg/dl (6.6 mmol/l). Using the IFG
(WHO) criterion of FPG 110 (6.1
mmol/l) and 126 mg/dl (7.0 mmol/l),
the RCBG cut point was 118 mg/dl (6.6
mmol/l), while for the IFG (ADA) crite-
rion of FPG100 mg/dl (5.6 mmol/l) and
126 mg/dl (7.0 mmol/l), the RCBG cut
point was 113 mg/dl (6.3 mmol/l).
CONCLUSIONS— The most com-
monly used tests for screening for type 2
diabetes are FPG and 2-h plasma glucose
(9,10). Measurement of RCBG has an ad-
vantage in that it can be undertaken at any
time of the day, does not require a veni-
puncture, and can even be performed by
laypeople. In studies from North Amer-
ica, RCBG cut points ranging from 99 to
140 mg/dl have been reported to identify
diabetes (5,12–14).
Our study presents the first such data
from India and shows that, in Asian Indi-
ans, RCBG cut points of 140 and 143
mg/dl (7.8 and 7.9 mmol/l) maximized
the sensitivity and specificity for diabetes.
Moreover, this study provides the first
data, to our knowledge, on RCPG cut
points for IGT (119 mg/dl [6.6 mmol/l]),
two definitions of IFG (WHO 118 mg/dl
and ADA 113 mg/dl), and abnormal glu-
cose tolerance (141 mg/dl) and regulation
(121 mg/dl).
The strengths of this study are that it
is based on a large number of subjects,
was performed in a “real life” community-
based setting, and is the first, to our
knowledge, to report on cut points for
IGT and IFG according to WHO and ADA
criteria.
Based on the findings of our study, we
propose that in opportunistic screening
studies in Asian Indians, all those with
RCBG values 110 mg/dl (6.1 mmol/l)
should receive more definitive tests for di-
abetes and pre-diabetes. This could not
only help limit the number of individuals
who must arrive for screening in a fasting
state but also reduce the costs of screen-
ing, as only 60% of those screened would
have RCBG 110 mg/dl.
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